Articles tagged as

Food and Drug Administration

  1. The Biggest Risks of Investing in Pfizer Stock

  2. How Will E-Cigarettes Affect Big Tobacco?

  3. ETF Analysis: ALPS Medical Breakthroughs

  4. Celgene Vs. Gilead: Vetting for the Best Biopharma

  5. ETF Analysis: Market Vectors Pharmaceutical

  6. 10 Developments By Gilead Sciences That Could Boost Profits

  7. How to Profit from the Generic Drug Trend

  8. How Does Biogen Make its Money?

  9. How NDAs Work and Why They're Important

  10. Could Amgen's Next Drug Be Worth $100 Billion?

  11. 3 Things That Could Hold Intuitive Surgical Back

  12. Did Orexigen Make A Big Mistake?

  13. Are These Biogen Idec's Next Blockbusters?

  14. Why Does Wall Street Hate MannKind?

  15. What’s The Drug That Will Finally Fight Obesity?

  16. Is Ariad On Track To Lose More Shares?

  17. What Is Amgen’s New Target?

  18. Will MannKind Finally Reach A Solid Ground?

  19. What Are The Real Economic Costs Of Obesity?

  20. Gilead Sciences: The New Market-Share Leader

  21. A Checklist For Successful Medical Technology Investment

  22. Getting Started In Stocks

  23. Top 4 Most Scandalous Insider Trading Debacles

  24. 8 Stages Of New Drug Development

  25. Investing In Medical Equipment Companies

  26. Using DCF In Biotech Valuation

  27. Investing In The Biotech Sector

  28. 4 Reasons Why You Love To Hate Big Businesses

  29. Evaluating Pharmaceutical Companies

  30. A Primer On The Biotech Sector

  31. Government Regulations: Do They Help Businesses?

  32. 7 Popular Diet Plans And What They Cost

  33. Baby Boomers Beware: Financial Fraud That Targets Seniors

  34. Scandals That Bring The CEOs Out

  35. Infamous Female Financiers

  36. A Year In Product Recalls

  37. Pharma Patent Trolls: Cheap Drugs At A Steep Price

  38. Investing In The Healthcare Sector

  39. Chasing Down Biotech Zombie Stocks

  40. The Ups And Downs Of Biotechnology

Trading Center